EANS-News: Marseille-Kliniken AG increases result in first quarter 2012/2013

Hamburg, Germany (euro adhoc) -

Corporate news transmitted by euro adhoc. The issuer/originator is solely responsible for the content of this announcement.

Subtitle: - EBIT development furthermore continued
- Revenues increased to EUR 50.0 million
- Continuous increase in occupancy rate to currently 90.6 percent

07 November 2012 - Marseille-Kliniken AG could
further increase its earning potential in the first three months of the current business year 2012/2013 (01 July 2012 until 30 September 2012). Another improvement of the occupancy rate to 90.6% (Q1 2011/2012: 88.5%) contributed to an increase in revenues by 3.7% to EUR 50.0 million (previous year: EUR 48.2 million). As expenditures in areas not directly belonging to care business could be slightly reduced despite the increased revenues, EBIT amounted to EUR 4.3 million. This means a significant profit improvement against EUR 3.0 million in the previous year. "We are very pleased with the current development. Anyhow our core business with the segments inpatient and outpatient care still shows vacancies of approximately 9%. At this point we see relevant potential which could not be achieved today, among others because of the general skills shortage in the nursing care sector", comments Michael Thanheiser, chairman of Marseille-Kliniken AG.

Marseille-Kliniken AG has built the basis for this continuing upward trend already in business year 2010/2011 by the implementation of a strategy mix consisting of focusing on care for the elderly, strengthening of quality leadership and introduction of a decentralised management structure. This tendency was confirmed by the currently published quarterly results. Net income increased to EUR 3.2 million (previous year: EUR 1.5 million), among others affected by an improved financial result.

Marseille-Kliniken AG sees this result as confirmation of its planning for the further operational development within the current business year 2012/2013. The company still expects revenues slightly above previous year's level and an increase in EBIT.

The complete report on the first three months of business year 2012/2013 such as additional shareholders' information is available for the public in the investor relations section on the company's website at www.marseille-kliniken.com.

---- End of press release ----

About Marseille-Kliniken AG:

Marseille-Kliniken AG (ISIN DE0007783003, WKN 778300, MKA) with its 57 residential care facilities, three residential units for assisted living and about 4,800 employees is a market leading listed company on health care in Germany. The business model is significantly influenced by the demographic development. Therefore Marseille-Kliniken AG has a secured future. Short-term economic fluctuations on the other hand exert only a minor influence. As a consistently modern company with strong focus on quality, the private enterprise is in a good position within a competitive environment primarily characterized by regionally active charities.

end of announcement euro adhoc

company: Marseille-Kliniken AG Alte Jakobstraße 79/80 D-10179 Berlin phone: +49 (0)30 246 32-400 FAX: +49 (0)30 246 32-401 mail: info@marseille-kliniken.de WWW: http://www.marseille-kliniken.de sector: Pharmaceuticals ISIN: DE0007783003 indexes: CDAX, Classic All Share, Prime All Share

stockmarkets: free trade: Berlin, Düsseldorf, Stuttgart, regulated dealing:
Hamburg, regulated dealing/prime standard: Frankfurt language: English

Digital press kit: http://www.ots.at/pressemappe/EASY_7994/aom

Rückfragen & Kontakt:

Hillermann Consulting
Jan Pahl
Investor Relations for Marseille-Kliniken AG
Poststraße 14-16
20354 Hamburg
Germany
Tel.: +49-(0)40 / 3202791-0
www.marseille-kliniken.com

ORIGINAL APA-OTS TEXT - THE INFORMATION CONTAINED IN THIS PRESS RELEASE IS SUBJECT TO THE EXCLUSIVE RESPONSIBILITY OF THE ISSUER | CNE0003